PetVivo (PETVW) CFO Granted 79,375 Restricted Shares at $0.76
Garry Lowenthal, Chief Financial Officer of PetVivo Holdings, Inc., received a grant of restricted common stock on 09/18/2025 as compensation for past performance.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Garry Lowenthal, Chief Financial Officer of PetVivo Holdings, Inc., received a grant of restricted common stock on 09/18/2025 as compensation for past performance. The grant consisted of 79,375 shares at a stated price of $0.76 and was issued to a corporation owned by Mr. Lowenthal. After the reported transaction, the reporting persons indirect beneficial ownership totaled 592,967 shares. The Form 4 indicates this was a non-derivative award recorded as an acquisition and identifies the grant as compensation rather than a market purchase.
Positive
- Alignment of incentives: Grant of restricted stock ties CFO compensation to company equity performance.
- Increased insider ownership: Indirect beneficial ownership rose to 592,967 shares, signaling continued management stake.
Negative
- Potential dilution: Issuing 79,375 shares increases share count and may dilute existing shareholders.
- Limited disclosure: Form 4 does not provide vesting schedule, approval authority, or total shares outstanding to assess materiality.
Insights
TL;DR: Executive received a restricted-stock compensation grant of 79,375 shares, modestly increasing indirect ownership.
The grant is a standard compensation mechanism tying the CFOs interests to equity performance. The transaction is non-derivative and was issued to an entity controlled by the reporting person, which preserves potential alignment with shareholders while concentrating ownership indirectly. With an acquisition price of $0.76 per share disclosed on the form, the immediate market impact is likely minimal unless this grant size represents a material portion of outstanding shares; the form does not state total shares outstanding so materiality cannot be assessed from this filing alone.
TL;DR: Compensation grant to a related entity is routine but should be disclosed clearly for governance transparency.
The filing clearly identifies the award as restricted common stock issued to a corporation owned by the reporting person as compensation for past performance, which is an acceptable practice when approved by the board or compensation committee. The indirect ownership disclosure is appropriate; however, the Form 4 does not include information about grant approval authority, vesting terms, or potential acceleration, which are relevant governance details for assessing incentives and alignment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 79,375 | $0.76 | $60K |
Footnotes (1)
- F1. Represents a grant of restricted common stock to a corporation owned by the Reporting Person as compensation for the Reporting Person's past performance.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did PetVivo (PETVW) report on this Form 4?
Who is the reporting person on the Form 4 for PetVivo (PETVW)?
Was the grant described as compensation or a market purchase?
AI-generated analysis. How Rhea-AI works. Not financial advice.